Evidence map›Paper›PMID 11483217›Full record

ArticleJournal of virological methods2001

Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction.

A Vabret, F Mouthon, T Mourez, S Gouarin, J Petitjean, F Freymuth

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 94 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Children in Coronaviruses' Wonderland: What Clinicians Need to Know.Mediterranean journal of hematology and infectious diseases · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. [New therapies against HCV].Revue francophone des laboratoires : RFL · 2016
    Article
  15. Article
  16. Update on Human Rhinovirus and Coronavirus Infections.Seminars in respiratory and critical care medicine · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A VabretLaboratory of Human and Molecular Virology, University Hopital, av. Georges Clemenceau, 14 033, Caen, France. vabret-a@chu-caen.fr
F Mouthon
T Mourez
S Gouarin
J Petitjean
F Freymuth
Hôpital Georges-Clemenceau · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An RT-PCR-hybridization was developed that amplified genetic material from the M protein gene of HCoV-229E and HCoV-OC43. The analytic sensitivity of these original primers were compared with primers defined in the N gene and described previously. The results show that 0.05 TCID50 of HCoV-229E and 0.01 TCID50 of HCoV-OC43 can be detected by this molecular method using the original method. Detection of HCoV-229E and HCoV-OC43 in clinical specimens is possible using this method: 348 respiratory specimens (202 sputum and 146 nasal aspirates) were tested with this RT-PCR-hybridization and 12 human coronavirus are detected (3%). The method could provide a useful tool for demonstrating the role of human coronavirus in infections of the respiratory tract.

Indexed as

Cell LineCoronavirusCoronavirus 229E, HumanCoronavirus InfectionsCoronavirus M ProteinsCoronavirus OC43, HumanDNA PrimersHumansReverse Transcriptase Polymerase Chain ReactionRNA, ViralSensitivity and SpecificityViral Matrix ProteinsCoronavirus M ProteinsDNA PrimersM protein, Human coronavirus OC43RNA, ViralViral Matrix Proteins

Identifiers

PMID11483217
PMCPMC7119936
OpenAlexW1985026938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.